Cyclin L1 antibody
Quick Overview for Cyclin L1 antibody (ABIN7464115)
Target
See all Cyclin L1 (CCNL1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human Cyclin L1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: 293T , 293T nuclear extract
Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.12 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Cyclin L1 (CCNL1)
-
Alternative Name
- cyclin L1
-
Background
- Cyclin L1 , ANIA6A , BM-001 , PRO1073 , ania-6a,Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.
-
Molecular Weight
- 60 kDa
-
Gene ID
- 57018
-
UniProt
- Q9UK58
Target
-